Recently, CNRAYSHIELD has successfully reached cooperation with Finnish customers with its professional technology and excellent quality in the field of nuclear medicine protection, and is about to complete the delivery of a batch of PETPig™ Syringe Shields. This is the second cooperation with our Finnish customers, which not only helps us consolidate the cooperative relationship between the two parties but also enhances our brand influence in the Nordic market.
The Tungsten PET Syringe Pig, with handles ordered by Finnish customers, is a core protection product developed by our company specifically for injecting radioactive drugs into nuclear medicine. The protective cover uses high-density tungsten alloy shielding material, which can effectively shield more than 95% of γ rays, and can significantly reduce the risk of radioactive material leakage while ensuring the safety of medical staff. Its unique ergonomic handle design can be adapted to a variety of syringes while meeting the convenience of one-handed operation, greatly improving the efficiency of clinical use. Moreover, the whole is composed of four detachable parts, which greatly improves the safety during transportation and injection operations.
The completion of this order is due to the high recognition of the quality of our products by Finnish customers. In the early communication, our technical team optimized the shielding performance, size specifications, capacity compatibility, etc. of the protective sleeve according to the actual needs of Finnish nuclear medicine diagnosis and treatment institutions, and finally stood out from many international suppliers.
To ensure the safe and efficient delivery of products, our company has set up a special working group to strictly control the production, quality inspection, packaging, and logistics links. All protective sleeves have passed the ISO 13485 medical equipment quality management system certification and are double-layered with vacuum sealing + shockproof foam to ensure that the products are not damaged during transportation. The goods will be shipped via a multimodal transport mode combining China-Europe trains and air transport, and are expected to arrive at the Port of Helsinki within 10 working days.
As a professional supplier in China’s nuclear medicine protection industry, CNRAYSHIELD has established cooperation with medical institutions in more than 30 countries and regions around the world, and its products are widely used in radioactive diagnosis and treatment scenarios such as radionuclide therapy and PET-CT examinations. If you have any questions about this product’s details or delivery time, don’t hesitate to get in touch with us at admin@cnrayshield.com. We look forward to your message.
Please Leave your message you want to know! We will respond to your inquiry within 24 hours!